Please use this identifier to cite or link to this item:
Title: Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine.
Austin Authors: Ching, M S;Blake, C L;Malek, N A;Angus, Peter W ;Ghabrial, Hany
Affiliation: Department of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Victoria, Australia
Issue Date: 1-Nov-2001
Publication information: Xenobiotica; the Fate of Foreign Compounds in Biological Systems; 31(11): 757-67
Abstract: 1. The inhibition of recombinant CYP1A1 and CYP1A2 activity by quinidine and quinine was evluated using ethoxyresorutin O-deethylation, phenacetin O-deethylation and propranolol desisopropylation as probe catalytic pathways. 2. With substrate concentrations near the Km of catalysis, both quinidine and quinine potently inhibited CYP1A1 activity with [I](0.5) approximately 1-3 microM, whereas in contrast, there was little inhibition of CYP1A2 activity. The Lineweaver-Burk plots with varying inhibitor concentrations suggested that inhibition by quinidine and quinine was competitive. 3. There was only trace metabolism of quinidine by recombinant CYP1A1, whereas rat liver microsomes as a control showed extensive consumption of quinidine and metabolite production. 4. This work suggests that quinidine is a non-classical inhibitor of CYP1A1 and that it is not as highly specific at inhibiting CYP2D6 as previously thought.
Gov't Doc #: 11765139
DOI: 10.1080/00498250110065603
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Type: Journal Article
Subjects: Acetaminophen.metabolism
Cytochrome P-450 CYP1A1.antagonists & inhibitors.genetics.metabolism
Cytochrome P-450 CYP1A2.genetics.metabolism
Cytochrome P-450 CYP1A2 Inhibitors
Enzyme Inhibitors.pharmacology
Microsomes, Liver.drug effects.metabolism
Recombinant Proteins.antagonists & inhibitors.genetics.metabolism
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Feb 3, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.